Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07113210 · ClinicalTrials.gov registry record · Phase 4
Quality of Life in Presbyopic Patients Who Are Treated With Qlosi
A Phase 4 study of Dry Eye and Presbyopia, sponsored by Southern College of Optometry.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
- 2
- Study locations
NCT07113210 is a Phase 4 study of Dry Eye and Presbyopia that is actively recruiting participants, run by Southern College of Optometry. The registered enrollment target is 36 participants, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (62% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT07113210, a Phase 4 study of Dry Eye and Presbyopia, is actively recruiting participants, sponsored by Southern College of Optometry.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to determine how Qlosi™ (pilocarpine HCL ophthalmic solution) 0.4%impacts the quality of life of participants with presbyopia by using a battery of validated and investigator-developed instruments * Improvement in presbyopic symptoms as measured with the Near Activity Visual Questionnaire-Presbyopia (NAVQ-P) when using Qlosi™ at week 4 compared to baseline (continuous variable). * Improvement in presbyopic symptoms as measured with the Visual Quality of Life with Time Survey (VisQualT) questionnaire when using Qlosi™ at week 4 compared to baseline.
Conditions Studied
Interventions
- DRUG pilocarpine HCL ophthalmic solution
Study Locations (2)
Minnesota
- Complete Eye Care of Medina - Medina
Tennessee
- The Southern College of Optometry - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2025-07-18 |
| Est. Completion | 2025-11-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07113210
The ClinicalTrials.gov registry entry for NCT07113210 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (62% lower). The listed sponsor is Southern College of Optometry, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Dry Eye appearing as the primary indexed condition, and to 1 intervention - of which pilocarpine HCL ophthalmic solution is the first listed.
NCT07113210 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Minnesota, Tennessee.
Frequently Asked Questions
What is clinical trial NCT07113210 about?
NCT07113210 is a clinical study titled "Quality of Life in Presbyopic Patients Who Are Treated With Qlosi". The goal of this clinical trial is to determine how Qlosi™ (pilocarpine HCL ophthalmic solution) 0.4%impacts the quality of life of participants with presbyopia by using a battery of validated and investigator-developed instruments * Improvement in presbyopic symptoms as measured with the Near Acti...
What is the current status of trial NCT07113210?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2025-07-18. Estimated completion is 2025-11-15.
What conditions does trial NCT07113210 study?
This clinical trial studies the following conditions: Dry Eye, Presbyopia, Glasses.
What interventions are being tested in trial NCT07113210?
The interventions under investigation include: pilocarpine HCL ophthalmic solution (DRUG).
Who is sponsoring clinical trial NCT07113210?
This trial is sponsored by Southern College of Optometry, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07113210 being conducted?
This trial has 2 study locations across Minnesota, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Kera Sol Tears on Signs and Symptoms of Surgical Temporary Ocular Discomfort Syndrome (STODS) in Subjects Following LASIK
RECRUITING · Phase 4
-
Impact of TRYPTYR on a Patient's Quality of Life and Ability to Perform Work
RECRUITING · Phase 4
-
Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease
RECRUITING · Phase 4
-
Performance of Systane PRO Versus Refresh Optive Mega-3
RECRUITING · Phase 4
-
A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months.
ACTIVE NOT RECRUITING · Phase 4
-
DOMPE -MT Neurotrophic Keratitis
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.